Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 1/2012

01.01.2012 | Original Paper

Social Stability and HIV Risk Behavior: Evaluating the Role of Accumulated Vulnerability

verfasst von: Danielle German, Carl A. Latkin

Erschienen in: AIDS and Behavior | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

This study evaluated a cumulative and syndromic relationship among commonly co-occurring vulnerabilites (homelessness, incarceration, low-income, residential transition) in association with HIV-related risk behaviors among 635 low-income women in Baltimore. Analysis included descriptive statistics, logistic regression, latent class analysis and latent class regression. Both methods of assessing multidimensional instability showed significant associations with risk indicators. Risk of multiple partners, sex exchange, and drug use decreased significantly with each additional domain. Higher stability class membership (77%) was associated with decreased likelihood of multiple partners, exchange partners, recent drug use, and recent STI. Multidimensional social vulnerabilities were cumulatively and synergistically linked to HIV risk behavior. Independent instability measures may miss important contextual determinants of risk. Social stability offers a useful framework to understand the synergy of social vulnerabilities that shape sexual risk behavior. Social policies and programs aiming to enhance housing and overall social stability are likely to be beneficial for HIV prevention.
Literatur
1.
Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14(Suppl 1):S11–21.PubMedCrossRef
2.
Blankenship KM, Friedman SR, Dworkin S, Mantell JE. Structural interventions: concepts, challenges and opportunities for research. J Urban Health. 2006;83(1):59–72.PubMedCrossRef
3.
Sweat MD, Denison JA. Reducing HIV incidence in developing countries with structural and environmental interventions. AIDS 1995;9 Suppl A:S251-7.:S251-S257.
4.
Klein C, Easton D, Parker R. Structural barriers and facilitators in HIV prevention: A review of international research. In: O’Leary A, editor. Beyond condoms: alternate approaches to HIV prevention. New York: Kluwer Academic Plenum Publishers; 2002. p. 17–46.
5.
AIDS Administration. The Baltimore HIV/AIDS Epidemiological Profile, Second Quarter 2006. Department of Health and Mental Hygiene.
6.
Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988–1998. Am J Epidemiol. 2002;156(7):641–53.PubMedCrossRef
7.
AIDS Administration. Baltimore City HIV/AIDS Epidemiological Profile, Fourth Quarter 2007.
8.
Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis. 2006;33(7 Suppl):S39–45.PubMed
9.
Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372(9635):337–40.PubMedCrossRef
10.
Howard G, Anderson RT, Russell G, Howard VJ, Burke GL. Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol. 2000;10(4):214–23.PubMedCrossRef
11.
Adler NE, Rehkopf DH. U.S. disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health. 2008;29:235–52.PubMedCrossRef
12.
Schulz A, Israel B, Williams D, Parker E, Becker A, James S. Social inequalities, stressors and self reported health status among African-American and white women in the Detroit metropolitan area. Soc Sci Med. 2000;51:1639–53.PubMedCrossRef
13.
Tucker JS, D’Amico EJ, Wenzel SL, Golinelli D, Elliott MN, Williamson S. A prospective study of risk and protective factors for substance use among impoverished women living in temporary shelter settings in Los Angeles County. Drug Alcohol Depend. 2005;80(1):35–43.PubMedCrossRef
14.
O’Leary A. Substance use, HIV. Disentangling the nexus of risk. J Subst Use. 2001;13:1–3.
15.
Farley TA. Sexually transmitted diseases in the Southeastern United States: location, race, and social context. Sex Transm Dis. 2006;33(7 Suppl):S58–64.PubMed
16.
Friedman SR. HIV-related politics in long-term perspective. AIDS Care Psychol Socio-Med Aspects AIDS/HIV. 1998;10(Suppl 2):93–103.
17.
Farmer P, Connors M, Simmons J., editors. Women, poverty, and AIDS: Sex, drugs, and structural violence. 1996; Monroe, Maine: Common Courage Press.
18.
Wechsberg WM, Dennis ML, Stevens SJ. Cluster analysis of HIV intervention outcomes among substance-abusing women. Am J Drug Alcohol Abuse. 1998;24(2):239–57.PubMedCrossRef
19.
Moore J, Schuman P, Schoenbaum E, Boland B, Solomon L, Smith D. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS. 1999;13(17):2459–68.PubMedCrossRef
20.
Lawrence JSS, Eldridge GD, Reitman D, Little CE, Shelby MC, Brasfield TL. Factors influencing condom use among African American women: implications for risk reduction interventions. Am J Commun Psychol. 1998;26(1):7–28.CrossRef
21.
Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. 2003;17(4):423–41.PubMedCrossRef
22.
Singer MC, Erickson PI, Badiane L, Diaz R, Ortiz D, Abraham T, et al. Syndemics, sex and the city: understanding sexually transmitted diseases in social and cultural context. Soc Sci Med. 2006;63(8):2010–21.PubMedCrossRef
23.
Straus R, Bacon SD. Alcoholism and social stability; a study of occupational integration in 2,023 male clinic patients. Q J Stud Alcohol. 1951;12(2):231–60.PubMed
24.
Gerard DL, Saenger G. Out-patient treatment of alcoholism: a study of outcome and its determinants. Toronto: University of Toronto Press; 1966.
25.
German D. Social stability and HIV risk: exploring the role of multidimensional social vulnerability (Doctoral dissertation). Available from Dissertations and Theses Database (UMI No. AAT 3357168). 2009.
26.
Angel RJ, Lein L, Henrici J. Poor families in America’s health care crisis. New York, NY: Cambridge University Press; 2006.CrossRef
27.
Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS. 2005;19(Suppl 3):S179–89.PubMedCrossRef
28.
Kalichman SC, Simbayi LC, Kagee A, Toefy Y, Jooste S, Cain D, et al. Associations of poverty, substance use, and HIV transmission risk behaviors in three South African communities. Soc Sci Med. 2006;62(7):1641–9.PubMedCrossRef
29.
Pearlin LI, Schieman S, Fazio EM, Meersman SC. Stress, health, and the life course: some conceptual perspectives. J Health Soc Behav. 2005;46(2):205–19.PubMedCrossRef
30.
Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, Moatti JP, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;31(SUPPL. 3):S149–53.PubMed
31.
Gibbs LE. A classification of alcoholics relevant to type-specific treatment. Int J Addict. 1980;15(4):461–88.PubMed
32.
Elbogen EB, Swanson JW, Swartz MS, Van Dorn R. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J Nerv Ment Dis. 2005;193(10):673–9.PubMedCrossRef
33.
McGuire JF, Rosenheck RA. Criminal history as a prognostic indicator in the treatment of homeless people with severe mental illness. Psychol Serv. 2004;55(1):42–8.CrossRef
34.
Gory ML, Ritchey FJ, Mullis J. Depression among the homeless. J Health Soc Behav. 1990;31(1):87–102.PubMedCrossRef
35.
Zlotnick C, Robertson MJ, Lahiff M. Getting off the streets: economic resources and residential exits from homelessness. J Commun Psychol. 1999;27(2):209–24.CrossRef
36.
Tomas A, Dittmar H. The experience of homeless women: an exploration of housing histories and the meaning of home. Hous Stud. 1995;10:493–515.CrossRef
37.
Weitzman B, Knickman J, Shinn M. Pathways to homelessness among New York City families. J Soc Issues. 2010;46:125–40.CrossRef
38.
Gebo KA, Keruly J, Moore RD. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Intern Med. 2003;18(2):104–11.PubMedCrossRef
39.
Welte J, Hynes G, Sokolow L, Lyons JP. Effect of length of stay in inpatient alcoholism treatment on outcome. J Stud Alcohol. 1981;42(5):483–91.PubMed
40.
Sheldon CT, Aubry TD, Arboleda-Florez J, Wasylenki D, Goering PN. Social disadvantage, mental illness and predictors of legal involvement. Int J Law Psychiatry. 2006;29(3):249–56.PubMedCrossRef
41.
Magdol L. Is moving gendered? The effects of residential mobility on the psychological well-being of men and women. Sex Roles. 2002;47:553–60.CrossRef
42.
Wistanley A, Thorns DC, Perkins HV. Moving house, creating home: exploring residential mobility. Hous Stud. 2002;17:813–32.CrossRef
43.
German D, Davey-Rothwell MA, Latkin CA. Residential transience and HIV risk behavior among injection drug users. AIDS Behav. 2007;11(6 Suppl):21–30.PubMedCrossRef
44.
Ware NC, Wyatt MA, Tugenberg T. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Soc Sci Med. 2005;61(3):565–76.PubMedCrossRef
45.
House JS, Umberson D, Landis KR. Structural and processes of social support. Annu Rev Sociol. 1988;14:293–318.CrossRef
46.
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef
47.
Wolitski RJ, Kidder DP, Fenton KA. HIV, homelessness, and public health: critical issues and a call for increased action. AIDS Behav. 2007;11(6 Suppl):167–71.PubMedCrossRef
48.
Aidala A, Cross JE, Stall R, Harre D, Sumartojo E. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS Behav. 2005;9(3):251–65.PubMedCrossRef
49.
Miller M, Neaigus A. An economy of risk: resource acquisition strategies of inner city women who use drugs. Int J Drug Policy. 2002;13(5):409–18.CrossRef
50.
Gillespie S, Kadiyala S, Greener R. Is poverty or wealth driving HIV transmission? AIDS. 2007;21(SUPPL. 7):S5–16.PubMedCrossRef
51.
Blankenship KM, Smoyer AB, Bray SJ, Mattocks K. Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system. J Health Care Poor Underserved. 2005;16(4 Suppl B):140–56.PubMedCrossRef
52.
Wohl DA, Rosen D, Kaplan AH. HIV and incarceration: dual epidemics. The AIDS Reader 2006;16(5):247–50, 257.
53.
Stall R, Mills TC, Williamson J, Hart T, Greenwood G, Paul J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93(6):939–42.PubMedCrossRef
54.
Choi KH, Binson D, Adelson M, Catania JA. Sexual harassment, sexual coercion, and HIV risk among U.S. adults 18–49 years. AIDS Behav. 1998;2(1):33–40.CrossRef
55.
DiIorio C, Dudley WN, Soet J, Watkins J, Maibach E. A social cognitive-based model for condom use among college students. Nurs Res. 2000;49(4):208–14.CrossRef
56.
Auerbach JD, Coates TJ. HIV prevention research: accomplishments and challenges for the third decade of AIDS. Am J Public Health. 2000;90(7):1029–32.PubMedCrossRef
57.
Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet. 2008;372(9641):845–59.PubMedCrossRef
58.
Des Jarlais D, Abdul-Quader A, Tross S. The next problem: maintenance of AIDS risk reduction among intravenous drug users. Int J Addict. 1991;26(12):1279–92.PubMed
59.
Oakley A, Fullerton D, Holland J. Behavioral interventions for HIV/AIDS prevention. AIDS. 1995;9(5):479–86.PubMed
60.
Rhodes T, Stimson G, Quirk A. Sex, drugs, intervention and research: from the individual to the social. Subst Use Misuse. 1996;31(3):375–407.PubMedCrossRef
61.
Auerbach J, Wypijewska C, Brodie H, Hammond K, editors. Institute of Medicine. AIDS and behavior: an integrated approach. 1994. Washington, DC, National Academy Press.
62.
Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav 1995;Spec No: 80–94.
Metadaten
Titel
Social Stability and HIV Risk Behavior: Evaluating the Role of Accumulated Vulnerability
verfasst von
Danielle German
Carl A. Latkin
Publikationsdatum
01.01.2012
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2012
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-9882-5

Weitere Artikel der Ausgabe 1/2012

AIDS and Behavior 1/2012 Zur Ausgabe

Commentary

Use of a Rapid HIV Home Test to Screen Sexual Partners: A Commentary on Ventuneac, Carballo-Diéguez, Leu et al. 2009

Original Paper

Changes in Stimulant Drug Use Over Time in the MACS: Evidence for Resilience Against Stimulant Drug Use Among Men Who Have Sex with Men

Original Paper

Social Network Characteristics and HIV Vulnerability Among Transgender Persons in San Salvador: Identifying Opportunities for HIV Prevention Strategies

Original Paper

Choice-Disability and HIV Infection: A Cross Sectional Study of HIV Status in Botswana, Namibia and Swaziland

Original Paper

Behavior, Intention or Chance? A Longitudinal Study of HIV Seroadaptive Behaviors, Abstinence and Condom Use

Original Paper

Mother’s CD4+ Count Moderates the Risk Associated with Higher Parity for Late Postnatal HIV-Free Survival of Breastfed Children: An Individual Patient Data Meta-Analysis of Randomized Controlled Trials

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise